Clinical Trial Update: Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer [NA]

View source ↗

Summary

A completed clinical trial comparing direct oral anticoagulants (DOACs) to LMWH with or without warfarin for venous thromboembolism in cancer patients; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Direct Oral Anticoagulants (DOACs)
• Low molecular weight heparin (LMWH) (low molecular weight heparin)
• Warfarin (warfarin)

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Cancer, Venous Thromboembolism | NA | Status: COMPLETED | Results posted: 2023-10-03